Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Total Revenue
136,110
127,342
133,841
172,794
Cost of Revenue
94,816
84,684
84,499
107,477
Gross Profit
41,294
42,658
49,342
65,317
Operating Expenses
Research Development
6,906
8,940
9,436
9,838
Selling General and Administrative
17,421
21,308
22,214
21,649
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
24,327
30,248
31,650
31,487
Operating Income or Loss
16,967
12,410
17,692
33,830
Income from Continuing Operations
Total Other Income/Expenses Net
(497)
(3,488)
(7,628)
(341)
Earnings Before Interest And Taxes
16,470
8,922
10,064
33,489
Interest Expense
16,694
19,292
20,194
21,485
Income Before Tax
(224)
(10,370)
(10,130)
12,004
Income Tax Expense
(5,308)
1,787
(2,544)
1,359
Minority Interest
--
--
--
--
Net Income From Continuing Ops
5,084
(12,157)
(7,586)
10,645
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
5,084
(12,157)
(7,586)
10,645
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
5,084
(12,157)
(7,586)
10,645